Cellectar Biosciences Inc (CLRB)

0.2535 -0.02 (-8.05%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Cellectar Biosciences Cash and Short Term Investments (Quarterly): 34.26M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CLRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ionis Pharmaceuticals Inc 2.483B
Ligand Pharmaceuticals Inc 219.64M
Revance Therapeutics Inc 184.08M
Zymeworks Inc 297.20M
Applied Therapeutics Inc 98.87M